CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 651 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01170091
NCT01170091N/ACompleted
CompareCT.gov

Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS

Boehringer Ingelheim·observational·Posted Jul 27, 2010·Updated Apr 11, 2014

In Brief

An observational study for Restless Legs Syndrome. Completed, enrolled 651 participants across 36 sites.

Detailed Summary

Safety and Effect of Mirapex(Pramipexole) tablet among Korean Restless Legs Syndrome Patients: An Open-Label, Postmarketing Surveillance Study

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRestless Legs Syndrome
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 27, 2010
Enrollment StartDec 1, 2007
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 15.9 years ago